Davis Thomas Andrew 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Oct 2, 2018
Insider Transaction Report
Form 4
Davis Thomas Andrew
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2018-10-01+500,000→ 500,000 totalExercise: $0.79Exp: 2028-10-01→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]1. The Stock Option shall become exercisable as to 25% of the maximum number of shares on October 1, 2019, and as to an additional 2.0833% of the total number of shares on each monthly anniversary thereafter